Expertise in
15
conditions

Dr. Philip Rosenthal

Pediatric Gastroenterology
Office
550 16th St, 
San Francisco, CA 
Clinical Trials:Currently Recruiting for 2 Trials
47 Years of Experience
Expertise in
15
conditions
Office
550 16th St, 
San Francisco, CA 

Overview

Philip Rosenthal is a Pediatric Gastroenterologist in San Francisco, California. Dr. Rosenthal has been practicing medicine for over 47 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Alagille Syndrome, Biliary Atresia, Cholestasis, Hepatitis, and Liver Transplant.

His clinical research consists of co-authoring 514 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatric Gastroenterology

Licenses

Pediatrics in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

Office
550 16th St, San Francisco, CA 94143

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
Enrollment Status: Recruiting
Publish Date: February 04, 2026
Intervention Type: Drug
Study Drugs: Methylprednisolone, Equine anti-thymocyte globulin, Prednisolone, Diphenhydramine
Study Phase: Phase 2
Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
Enrollment Status: Recruiting
Publish Date: September 08, 2025
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency (AATD) [SEQUOIA]
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Other, Drug
Study Drug: ARO-AAT
Study Phase: Phase 2
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Open-Label, Phase 2 Study to Evaluate the Safety and Tolerability of Maralixibat in the Treatment of Infants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis and Alagille Syndrome
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drug: Maralixibat
Study Phase: Phase 2
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: Odevixibat
Study Phase: Phase 3
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Enrollment Status: Completed
Publish Date: February 23, 2022
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
Enrollment Status: Terminated
Publish Date: October 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: A Pilot Withdrawal/Reinstitution Trial
Enrollment Status: Completed
Publish Date: October 26, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

513 Total Publications

Accuracy of Plasmodium falciparum genetic data for estimating parasite prevalence and malaria incidence in Uganda.
Accuracy of Plasmodium falciparum genetic data for estimating parasite prevalence and malaria incidence in Uganda.
Journal: Research square
Published: January 09, 2026
Similar Doctors
Paul Harmatz
Expertise in
11
conditions
Dr. Paul Harmatz
Pediatric Gastroenterology
Expertise in
11
conditions
Dr. Paul Harmatz
Pediatric Gastroenterology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (9.4 miles away)
510-428-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Paul Harmatz is a Pediatric Gastroenterologist who specializes in mucopolysaccharidoses (MPS) and other lysosomal storage diseases. He is the Medical Director of the Pediatric Clinical Research Program in Mucopolysaccharidoses (MPS) and Related Disorders at UCSF Benioff Children's Hospital. Dr. Harmatz has been the Principal Investigator on multiple clinical trials involving MPS and its variants. He is licensed to practice in CA. Dr. Harmatz is highly rated in 11 conditions, according to our data. His top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Mucopolysaccharidosis Type 4 (MPS IV, Morquio Syndrome).

Expertise in
6
conditions
Dr. Sohail Husain
Pediatric Gastroenterology
Expertise in
6
conditions
Dr. Sohail Husain
Pediatric Gastroenterology

Office

750 Welch Rd Ste 116, 
Palo Alto, CA 
 (26.8 miles away)
650-498-5605
Languages Spoken:
English
See accepted insurances

Sohail Husain is a Pediatric Gastroenterologist in Palo Alto, California. Dr. Husain is highly rated in 6 conditions, according to our data. His top areas of expertise are Childhood Pancreatitis, Hereditary Pancreatitis, Acute Pancreatitis, Endoscopy, and Gallbladder Removal.

Expertise in
9
conditions
Dr. Melvin Heyman
Pediatric Gastroenterology
Expertise in
9
conditions
Dr. Melvin Heyman
Pediatric Gastroenterology

Office

5565 W Las Positas Blvd Ste 140, 
Pleasanton, CA 
 (30.5 miles away)
925-598-3500
Languages Spoken:
English
See accepted insurances

Melvin Heyman is a Pediatric Gastroenterologist in Pleasanton, California. Dr. Heyman is highly rated in 9 conditions, according to our data. His top areas of expertise are Childhood Pancreatitis, Chronic Pancreatitis, Viral Gastroenteritis, Endoscopy, and Colonoscopy.

Frequently Asked Questions about Dr. Philip Rosenthal

How do I make an appointment with Dr. Philip Rosenthal?

You can book an appointment with Dr. Philip Rosenthal by calling their office at 415-476-5892. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Philip Rosenthal a top-rated expert for Alagille Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Philip Rosenthal is classified as an Elite expert for Alagille Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Philip Rosenthal specialize in?

While Dr. Philip Rosenthal is a Pediatric Gastroenterology, they have specific expertise in Alagille Syndrome, Biliary Atresia, and Cholestasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Gastroenterology.

Does Dr. Philip Rosenthal participate in research or clinical trials?

Yes. Dr. Philip Rosenthal has published 513 articles and abstracts on conditions like Alagille Syndrome. You can view a list of Dr. Philip Rosenthal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Philip Rosenthal accept my insurance?

Dr. Philip Rosenthal accepts most major insurance plans, including Humana and Medicaid. We recommend calling the office directly at 415-476-5892 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile